Welcome News! The Supreme Court Proposes to Ditch the Amicus Brief Consent Requirement

The Supreme Court recently proposed to eliminate the requirement to obtain the parties’ consent, or the Court’s permission, to file an amicus brief. I have written a short insight piece for DRI’s new online publication, The Brief Case, about this important development. My article raises a fundamental point about amicus briefs: Since the purpose of […]

Welcome News! The Supreme Court Proposes to Ditch the Amicus Brief Consent Requirement Read More »

Amicus Brief Webinar for King County (Washington) Bar Association

I am delighted that the King County (Washington) Bar Association invited me to present to its members a 60-minute webinar on drafting effective amicus briefs and using them strategically. The webinar, presented live on March 14, 2022, was moderated by Rory Cosgrove of Carney Badley Spellman in Seattle. Rory is a former chair the bar

Amicus Brief Webinar for King County (Washington) Bar Association Read More »

Webinar on Supreme Court Practice

On March 4, 2022, I was pleased to participate in a 90-minute continuing legal education webinar titled “Procedures, Practice Pointers, & Winning Strategies When Your Case is Headed to the U.S. Supreme Court.” The webinar, sponsored by the DuPage County (Illinois) Bar Association, emphasized written Supreme Court advocacy at the certiorari-petition stage, which is where

Webinar on Supreme Court Practice Read More »

Amicus Brief Webinar for Beverly Hills Bar Association

On January 14, 2022 I had the privilege of presenting a live webinar for the Beverly Hills Bar Association titled Friendly Persuasion: Drafting Effective Amicus Briefs & Using Them Strategically. BHBA President-Elect, Malcolm McNeil,  and a member of the Board of Directors of the Atlantic Legal Foundation, engaged me in a 60-minute conversation that covered

Amicus Brief Webinar for Beverly Hills Bar Association Read More »

Hispanic-Americans May Be the Real Victims of the Flanax Litigation

The following commentary was originally published by Jurist on November 5, 2021. My client, Jamie Belcastro, a registered pharmacist, started Belmora LLC, a small, Virginia-based company that sells nonprescription Flanax pain relief products, about 20 years ago. For much of this time Bayer AG, the multinational pharmaceutical corporation headquartered in Germany—whose gross revenues approach $

Hispanic-Americans May Be the Real Victims of the Flanax Litigation Read More »

D.C. Circuit’s Exploratory Data Ruling Is A Win For Transparency

When scientists employed by universities, nonprofit institutes, or corporations publish scientific studies, they routinely make their underlying research data available to peer reviewers and anyone else who is interested. A recent D.C. Circuit decision¸ Pavement Coatings Technology Council v. United States Geological Survey, 995 F.3d 1014 (D.C. Cir. 2021), confirms that federal government scientists should

D.C. Circuit’s Exploratory Data Ruling Is A Win For Transparency Read More »

R Street Institute Panel: Scientific Evidence In the Courtroom

On September 9, 2021 I participated in a panel discussion on Scientific Evidence In the Courtroom.  The panel, part of a virtual event on sponsored by the R Street Institute, was moderated by R Street Fellow Anthony Marcum and also included former Boston Scientific General Counsel Tim Pratt. Our panel focused on the trial court

R Street Institute Panel: Scientific Evidence In the Courtroom Read More »

Panel: Strategic Use of Amicus Briefs In Appellate Litigation

On May 27, I moderated and participated in a lively panel discussion on Strategic Use of Amicus Briefs In Appellate Advocacy.  Steve Lehotsky of  Lehotsky Keller LLP and Richik Sarkar of Dinsmore & Shohl LLP joined me in the discussion, which was part of the DRI Appellate Advocacy Committee’s annual seminar. Amicus curiae briefs have

Panel: Strategic Use of Amicus Briefs In Appellate Litigation Read More »

Keep Junk Science Away From Juries

Law360 has published my Expert Analysis/Opinion, Keep Junk Science Away From Juries. The article explains that juries are being called upon to assess an increasingly broad range of scientific issues—ranging from medical causation in class-action/mass-action product liability litigation to the alleged effects of fossil-fuel emissions in climate-change damages suits. For this reason, trial judges’ “gatekeeper”

Keep Junk Science Away From Juries Read More »

Scroll to Top